Stockholders' Equity |
Shareholders' EquityThe following tables summarize our shareholders’ equity activity for the three and six months ended June 30, 2025 and June 30, 2024, respectively: | | | | | | | | | | Paid-in Capital in Excess of Par Value | | | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interest in Consolidated Subsidiaries | | Balance at December 31, 2024 | | | | | | | | Comprehensive income (loss): | | | | | | | | | | | | | | | | Other comprehensive income (loss) | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at March 31, 2025 | | | | | | | | Comprehensive income (loss): | | | | | | | | | | | | | | | | Other comprehensive income (loss) | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | In the first quarter and second quarter of 2025, we issued common stock from treasury shares for stock options exercised, restricted stock grants, performance shares under our performance unit program, and purchases under our employee stock purchase plan. |
| | | | | | | | | | Paid-in Capital in Excess of Par Value | | | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interest in Consolidated Subsidiaries | | Balance at December 31, 2023 | | | | | | | | Comprehensive income (loss): | | | | | | | | | | | | | | | | Other comprehensive income (loss) | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at March 31, 2024 | | | | | | | | Comprehensive income (loss): | | | | | | | | | | | | | | | | Other comprehensive income (loss) | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | In the first quarter and second quarter of 2024, we issued common stock from treasury shares for stock options exercised, restricted stock grants, performance shares under our performance unit program, and purchases under our employee stock purchase plan. As a result, additional paid in capital was reduced to zero in each quarter, which resulted in a reduction of retained earnings by $3 million in the first quarter of 2024 and $96 million in the second quarter of 2024. Future issuances from treasury shares could similarly impact additional paid in capital and retained earnings. |
Our Board of Directors has authorized a program to repurchase our common stock from time to time. We repurchased 12 million shares of our common stock under the program during the three months ended June 30, 2025 for $252 million. Approximately $2.5 billion remained authorized for repurchases under the program as of June 30, 2025. From the inception of this program in February of 2006 through June 30, 2025, we repurchased 305 million shares of our common stock for a total cost of approximately $11.6 billion. We repurchased 6.9 million shares of our common stock under the program during the three months ended June 30, 2024 for approximately $251 million. Accumulated other comprehensive loss consisted of the following: | | | | | | | | | Cumulative translation adjustments | | | Defined benefit and other postretirement liability adjustments | | | | | | Total accumulated other comprehensive loss | | |
|